European Leukemia Trial Registry
Trial: EuroSKI

More Details
Title Stopping TKI in patients with CML in complete molecular remission (MR4)
Scientific Title Multicenter prospective trial estimating the persistence of molecular remission in chronic myeloid leukemia after stopping TKI
Short Title EuroSKI
Trialgroup CML-Studiengruppe
Type of Trial NIS, multicentric, single-group, prospective, open-label
Disease Chronic myeloid leukemia(CML) Chronic Phase
Age >= 18 years
Status Closed
Start of Recruitment 31.05.2012
Leader Saußele, Prof. Dr. med., Susanne
Contactperson

principal investigator
Mahon, Prof. Dr., François-Xavier
Email: francois‐xavier.mahon@umr5540.u‐bordeaux2.fr

Biometrics
Guilhot, Dr. med., Francois
Tel: +33 (0)549 444201
Email: f.guilhot@chu-poitiers.fr

Biometrics
Pfirrmann, Dr., Markus
Tel: +49 (0)89 544201-40
Fax: +49 (0)89 544201-44
Email: pfi@ibe.uni-muenchen.de
Homepage: http://www.ibe.med.uni-muenchen.de/

Quality of life
Efficace, PhD, Fabio
Email: f.efficace@gimema.it

Administrative needs
Leopold, Susanne
Tel: +49 (0)621 383 6970
Fax: +49 (0)621 383 6969
Email: susanne.leopold@medma.uni-heidelberg.de

Study assistance
Bartsch, Gabriele
Tel: +49 (0)621 383 6965
Fax: +49 (0)621 383 6969
Email: gabriele.bartsch@medma.uni-heidelberg.de

Shortprotocol Shortprotocol
created 02.07.2012 Sina Hehn
changed 12.07.2016 Eva-Maria Ableidinger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org